Capital West advises Transferra Nanosciences Inc. on its sale to Evonik Industries
Founded in 1991 as a start-up out of the University of British Columbia, Transferra Nanosciences Inc., formerly Northern Lipids Inc., is a contract development and manufacturing organization. Based in Burnaby, BC, Transferra provides products and services to life science companies engaged in the development of pharmaceutical products, primarily in the lipid nanoparticle field.
Evonik Industries, headquartered in Essen, Germany, is a global specialty chemicals group with annual sales in excess of $15 billion dollars. Evonik has three operating segments – nutrition & care, resource efficiency and performance materials. The Transferra acquisition is a strategic addition to their nutrition & care segment.
In this transaction, Capital West Partners acted as exclusive financial advisor to Transferra.
For additional information contact: